Home Company Team Technology Products Investors Contact Us

Electronic Detection

Multiplexed Analysis

Intellectual Property

Intellectual Property

Core to Ohmx’s technology is its IP portfolio, which began with licenses for 41 patents developed by its founder, Northwestern University Professor Thomas Meade, PhD. Ohmx has recently had 10 patent applications granted and two allowed.

In addition to our core detection technology, the Ohmx IP portfolio includes patents for reagentless approaches, multiplexing methods, pharmaceutical bioprocess solutions, enzymatic function studies, a novel biomarker for prostate cancer and innovative biosensor components.

If you are interested in learning more about Ohmx patents or licensing opportunities, please visit the Ohmx Newsroom, or see more information on Partnering.

[back to top ]


Design by Digizyme